G. Michael Landis - 18 Feb 2026 Form 4 Insider Report for Polaryx Therapeutics, Inc. (PLYX)

Signature
/s/ G. Michael Landis
Issuer symbol
PLYX
Transactions as of
18 Feb 2026
Net transactions value
+$7,991
Form type
4
Filing time
20 Feb 2026, 16:41:55 UTC
Previous filing
29 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Landis G. Michael Chief Financial Officer, Director SOUTH TOWER, 140 E RIDGEWOOD, AVENUE, SUITE 415, PARAMUS /s/ G. Michael Landis 20 Feb 2026 0001548560

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLYX Common Stock Purchase $7,991 +2,867 +1.3% $2.79 228,225 18 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.